Oxytocin is an endogenous peptide hormone that is synthesized in the hypothalamus and secreted by the posterior pituitary gland. It promotes uterine contraction by binding to G-protein-coupled oxytocin receptors on myometrial cells, thereby increasing intracellular calcium and enhancing actin-myosin interaction. In obstetric practice, oxytocin is administered after the delivery of the neonate during a C-section to promote uterine tone and reduce the risk of postpartum hemorrhage (PPH), which is a leading cause of parental morbidity and mortality. Despite its widespread use, the optimal infusion rate of oxytocin that provides adequate uterine contractility while minimizing side effects remains a subject of ongoing debate.
Oxytocin has a rapid onset but a short plasma half-life of approximately four to ten minutes, requiring continuous infusion to maintain uterine tone once the initial bolus effect subsides. Excessive dosing can cause hypotension, tachycardia, and nausea due to vasodilation and negative inotropic effects. Insufficient dosing, on the other hand, risks uterine atony and bleeding. Thus, identifying the lowest infusion rate that maintains adequate tone without hemodynamic instability is critical.
A prospective randomized trial by Duffield et al. (2017) compared high and low oxytocin infusion rates after elective C-sections. Both groups achieved similar uterine tone; however, higher rates (7.5 U/h) produced greater hemodynamic fluctuations. The authors concluded that lower infusion rates—around 2.5 to 5 U/h—are generally sufficient for maintaining uterine contractility without cardiovascular compromise (2). Similarly, Mohta et al. (2021) found that a 2.5 U/h infusion following a 3 U bolus effectively maintained uterine tone under spinal anesthesia; no additional benefit was observed at higher infusion rates (3).
Although these studies suggest a general maintenance range of 2.5 to 5 U/h, oxytocin requirements can vary significantly among patients. In laboring patients who have already received oxytocin, receptor desensitization can result in a diminished uterine response. However, Mohta et al. (2022) demonstrated that moderate infusion rates of approximately 2.4 U/h were sufficient to maintain uterine tone during non-elective cesarean sections in this group. This finding suggests that complete receptor desensitization is uncommon and that standard maintenance doses remain effective. Other physiological variables, such as parental weight, circulating blood volume, and receptor sensitivity, may also influence oxytocin pharmacodynamics. This explains why some people require slightly higher infusion rates within the same therapeutic range to achieve optimal uterine tone.
Another consideration is hemodynamic management under spinal anesthesia. Oxytocin can cause dose-dependent hypotension through peripheral vasodilation. Phenylephrine, an α₁-adrenergic agonist commonly used to counteract hypotension induced by spinal anesthesia, helps maintain systemic vascular resistance and arterial pressure. Jin et al. (2023) reported that combining prophylactic phenylephrine with oxytocin permitted lower oxytocin infusion rates while maintaining stable blood pressure and adequate uterine tone. This demonstrates beneficial pharmacologic synergy (5).
Taken together, these studies suggest that an oxytocin infusion rate of 2–5 U/h following a bolus of 1–3 U achieves optimal uterine tone for most C-section patients. Doses above this range provide little additional benefit and increase the risk of hypotension and tachycardia. The most prudent approach is to titrate oxytocin based on the individual patient’s uterine response and hemodynamic status rather than relying on fixed dosing protocols. Future research should focus on individualized dosing algorithms that account for patient weight, prior oxytocin exposure, and receptor sensitivity to further improve safety and efficacy.
References
1. Sharpe EE, Sviggum HP. Oxytocin protocols during Cesarean delivery: optimizing the tone zone. Can J Anaesth. 2024;71(10):1344-1348. doi:10.1007/s12630-024-02829-8
2. Duffield A, McKenzie C, Carvalho B, et al. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial. Anesth Analg. 2017;124(3):857-862. doi:10.1213/ANE.0000000000001658
3. Mohta M, Chowdhury RB, Tyagi A, Agarwal R. Efficacy of different infusion rates of oxytocin for maintaining uterine tone during elective caesarean section: A randomised double blind trial. Anaesth Intensive Care. 2021;49(3):183-189. doi:10.1177/0310057X20984480
4. Mohta M, Siddiqui S, Chilkoti GT, Agarwal R. Oxytocin infusion rates for maintaining uterine tone during non-elective cesarean section in laboring patients: a randomized, controlled trial. J Anesth. 2022;36(4):456-463. doi:10.1007/s00540-022-03067-2
5. Jin XQ, Shen YH, Fu F, Yu J, Xiao F, Huang XD. Oxytocin infusion for maintenance of uterine tone under prophylactic phenylephrine infusion for prevention of post-spinal hypotension in cesarean delivery: a prospective randomised double-blinded dose-finding study. BMC Pregnancy Childbirth. 2023;23(1):840. Published 2023 Dec 6. doi:10.1186/s12884-023-06165-5